SynthesisBMC public health2023
Disability-adjusted life years (DALYs) based COVID-19 health impact assessment: a systematic review.
Synthesis in BMC public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 2 syntheses or guidelines pooled it, 23 citations in OpenAlex.
- The burden of COVID-19 based on disability-adjusted life years: a systematic review of available evidence.Frontiers in public health · 2025Pooled it
- Organokines in COVID-19: A Systematic Review.Cells · 2023Pooled it
- Global, regional, and national burden and trends of neonatal encephalopathy.Pediatric research · 2026Article
- Hypertensive heart disease attributable to high BMI: global trends, gender disparities, and SDI-based inequalities (1990-2021).Journal of human hypertension · 2026Article
- Global burden of disease attributable to high fasting plasma glucose from 1990 to 2021: a spatiotemporal analysis of global burden of disease 2021.Frontiers in cardiovascular medicine · 2026Article
- Trends and cross-country inequities by region, sex, age in the mortality, incidence, and disability-adjusted life years of COVID-19: Analysis from the Global Burden of Disease Study 2021.PLoS neglected tropical diseases · 2025Article
- Global burden of atherosclerotic cardiovascular disease attributed to lifestyle and metabolic risks.Science China. Life sciences · 2025Article
- The Impact of Long COVID on Employment and Well-Being: A Qualitative Study of Patient Perspectives.Journal of general internal medicine · 2025Article
- Article
- Infectious Causes of Death: An Autopsy-Based Study of 546 Cases.Open forum infectious diseases · 2025Article
- Food safety practices of individuals before and after the emergence of COVID-19: A pre- and post-comparative analysis.PloS one · 2025Article
- Global burden of children and adolescents' nutritional deficiencies from 1990 to 2021.Frontiers in pediatrics · 2025Article
- Protection conferred by booster vaccine doses in hospitalized patients with COVID-19 during the SARS-CoV-2 Omicron BA.2 and BA.5 epidemics from 2022 to 2023 in Greece.Infectious medicine · 2024Article
- Burden of disease attributable to high body mass index: an analysis of data from the Global Burden of Disease Study 2021.EClinicalMedicine · 2024Article
- Association between long COVID and vaccination: A 12-month follow-up study in a low- to middle-income country.PloS one · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe emergence of COVID-19 has resulted in health, socio-economic, and political crises. The overall health impact of this disease can be measured by disability-adjusted life years (DALYs) which is the sum of the life years lost due to disability (YLDs) and the years life lost due to premature death (YLLs). The overarching objective of this systematic review was to identify the health burdens of COVID-19 and summarise the literature that can aid health regulators to make evidence-based decisions on COVID-19 mitigation strategies.
methodsThis systematic review was conducted using the PRISMA 2020 guidelines. DALYs-based primary studies were collected from databases, manual searches, and included studies' references. The primary studies published in English language, conducted since the emergence of COVID-19, and using DALYs or its subsets (years life lost due to disability and/or years life lost due to premature death) as health impact metrics, were the inclusion criteria. The combined disability and mortality health impact of COVID-19 was measured in DALYs. The risk of bias due to literature selection, identification, and reporting processes was assessed using the Joanna Bridges Institute critical appraisal tool for cross-sectional studies, and the certainty of evidence was assessed using the GRADE Pro tool.
resultOf the 1459 identified studies, twelve of them were eligible for inclusion in the review. The years life lost due to COVID-19 related mortality was dominant over the years life lost due to COVID-19 related disability (disability times from the onset of COVID-19 to recovery, from diseases occurrence to mortality, and the long-term consequences of COVID-19) in all included studies. The long-term consequence disability time and the pre-death disability time were not assessed by most of the reviewed articles.
conclusionThe impact of COVID-19 on both the length and quality of life has been substantial and has been causing considerable health crises worldwide. The health burden of COVID-19 was greater than other infectious diseases. Further studies focussing on issues examining increasing preparedness for future pandemics, public sensitization, and multi-sectorial integration are recommended.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.